Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03430791
Title Trial of Combination TTF(Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Baptist Health South Florida



Ipilimumab + Nivolumab


Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Miami Cancer Institute at Baptist Health, Inc. Miami Florida 33176 United States Details
*Shaded cells indicate that there was no data available from for the field